Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests
Go back to Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests| Exact Sciences Corp (NASDAQ: EXAS) | Delayed: 104.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.91 | 52 Week High | $22.80 | |||
| Open | $104.91 | 52 Week Low | $4.67 | |||
| Day High | $104.91 | P/E | N/A | |||
| Day Low | $104.91 | EPS | $-0.69 | |||
| Volume | 239,865 | |||||
